Tamara van Donge

Chapter 2 34 practice. Bedside decision support tools should be developed to facilitate optimizing and individualizing treatment strategies in vulnerable patient populations such as pregnant women and their fetuses and newborns. Quantitative pharmacology and pharmacometric approaches have the potential to further personalize and enhance patient care allowing safe and efficacious use of drugs during pregnancy and neonatal life.